Hydration Pharmaceuticals (HPC) Stock Overview
The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
HPC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
The Hydration Pharmaceuticals Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.005 |
| 52 Week High | AU$0.02 |
| 52 Week Low | AU$0.004 |
| Beta | 0.95 |
| 1 Month Change | -16.67% |
| 3 Month Change | -50.00% |
| 1 Year Change | -75.00% |
| 3 Year Change | -95.45% |
| 5 Year Change | n/a |
| Change since IPO | -98.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| HPC | AU Personal Products | AU Market | |
|---|---|---|---|
| 7D | 0% | 4.3% | 0.05% |
| 1Y | -75.0% | -16.3% | 5.8% |
Return vs Industry: HPC underperformed the Australian Personal Products industry which returned -23.4% over the past year.
Return vs Market: HPC underperformed the Australian Market which returned 5.9% over the past year.
Price Volatility
| HPC volatility | |
|---|---|
| HPC Average Weekly Movement | 22.0% |
| Personal Products Industry Average Movement | 8.6% |
| Market Average Movement | 9.4% |
| 10% most volatile stocks in AU Market | 18.1% |
| 10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: HPC's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: HPC's weekly volatility has decreased from 27% to 22% over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Oliver Baker | hydralyte.com |
The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. The company sells its products under the Hydralyte brand through retail stores and online. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is based in Melbourne, Australia.
The Hydration Pharmaceuticals Company Limited Fundamentals Summary
| HPC fundamental statistics | |
|---|---|
| Market cap | AU$2.15m |
| Earnings (TTM) | -AU$6.86m |
| Revenue (TTM) | AU$4.38m |
Is HPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HPC income statement (TTM) | |
|---|---|
| Revenue | US$2.93m |
| Cost of Revenue | US$1.33m |
| Gross Profit | US$1.60m |
| Other Expenses | US$6.19m |
| Earnings | -US$4.59m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.011 |
| Gross Margin | 54.57% |
| Net Profit Margin | -156.64% |
| Debt/Equity Ratio | 0% |
How did HPC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/05 12:57 |
| End of Day Share Price | 2026/01/05 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
The Hydration Pharmaceuticals Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.